BridgeMD
What laxatives after hip surgery?
EU CTIS ID: 2024-513871-42-00
What this study is testing
The aim is to investigate how to prevent constipation best after hip surgery using laxatives.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- • Acute hip fracture surgery patients from one of two orthopedic departments from hospitals in the Southern Region of Denmark. • Age≥ 65 years • The patients should be able to speak and understand Danish
You likely can't join if
- with known chronic constipation (defined from Wexner constipation score) • with known use of laxatives at admission • who participate in other similar clinical studies • who is terminally ill • who is restraint • who is in isolation • with severe heart disease defined as New York Heart Association (NYHA) III og IV • with severe chronically inflammatory bowel disease • with acute abdominal surgical conditions, eg. ileus, obstruction or perforation • with dysphagia where the patient can not swallow tablets/oral liquids • with toxic megacolon • with gastric emptying disorder • with severe electrolyte disorder (P-kalium: < 2.5 mmol/l og P-natrium: <125 mmol/l) • Allergies to the ingredients • Pregnant women can not be included but the women are expected to be postmenopausal why pregnancy test are not performed
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.